Delivery Order SPE2DB20D3103-SPE2DB22FP2Y6
Award Date 7/25/22
Potential Completion Date 7/26/22
Potential Value $4.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humira (CF) Pen 40 mg/0.4 mL. The contract, valued at $32,788.12, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award, valued at $1,794.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (CF) Pen 40 mg/0.4 mL, a specialty medication used for various medical conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Humira (CF) Pen 40 mg/0.4 mL. The contract has a Firm Fixed Price (FFP) pricing type and a ceiling value of $9,816.80. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. This IDC serves as the...
- This federal contract award, valued at $7,046.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a $43,798.19 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (CF) Pen 40 mg/0.4 mL medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Humira (CF) Pen 40 mg/0.4 mls pharmaceutical products. The $2,770.74 award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 to provide a comprehensive range of medications and medical supplies to military treatment programs and facilities worldwide. The IDC was awarded...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Humira(CF) Pen 40 mg/0.4 mls. The contract has a firm fixed price of $8,418.89 and a completion date of May 2, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,046.64 fixed-price delivery order is for the supply of Humira (CF) Pen 40 mg/0.4 mL, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (CF) Pen 40 mg/0.4 mL medication. The contract is a Delivery Order valued at $4,156.11 with a firm fixed price and an ultimate completion date of May 14, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is registered in the System for Award Management (SAM.gov) and operates as a...
- This federal contract award, valued at $1,847.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira(CF) Pen 40 mg/0.4 mLs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FP2Y6Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (CF) Pen 40 mg/0.4 mL. The $4,512.72 firm fixed-price delivery order was placed under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc., which runs through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract was awarded on an unrestricted, full and open competition basis without any set-aside designations.
Generated 2/27/25, 1:23 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 7/25/22 |